Neuronetics Reports Record First Quarter 2024 Financial and Operating Results [Yahoo! Finance]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the first quarter of 2024. First Quarter 2024 Highlights First quarter 2024 revenue of $17.4 million, a 12% increase as compared to the first quarter 2023 U.S. treatment session revenue increased by 22% versus the first quarter of 2023 U.S. NeuroStar Advanced Therapy system revenue of $3.3 million, in the quarter; the Company shipped 41 systems Recent Operational and Marketing Highlights NeuroStar Advanced Therapy received FDA clearance as a first line, adjunct treatment for major depressive disorder in adolescents aged 15-21 Launched second cohort within the “Better Me Guarantee Provider” pilot program in January 2024 and the third cohort in April 2024 Announced an expanded exclusive commercial partnership with Transformations Care Network ("TCN") Achieved
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsGlobeNewswire
- Neuronetics, Inc. (NASDAQ: STIM) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.MarketBeat
- Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
- Neuronetics: Reality Set In [Seeking Alpha]Seeking Alpha
- Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
STIM
Earnings
- 5/7/24 - Beat
STIM
Sec Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 5/7/24 - Form 8-K
- STIM's page on the SEC website